News Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics Staff September 11, 2023 Iframe sync Post navigation Previous: XORTX Announces Participation at Upcoming Investor ConferencesNext: InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904 More Stories Fitness News UREVO Announces Black Friday Sale 2026 with Its Biggest Discounts of the Year Staff November 18, 2026 News Pharmaceutical Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 3 at the Increased Dose of 15 mg/kg in Entrada Therapeutics’ ELEVATE-45-201 Study Staff November 18, 2026 Cancer Clinical Trial Diagnostics DNA Medicare News Patient Care Pharmaceutical Adaptive Biotechnologies Highlights clonoSEQ’s Central Role in Advancing MRD-Guided Care Across Hematology at ASH 2026 Staff November 18, 2026